None listed
Conditions
Interventions
None listed
Sponsors
Chonnam National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who had a diagnosis of open angle glaucoma, in at least one eye, and received monotherapy with bimatoprost 0.01% once daily are included. Each patient has to have been followed regularly for more than 1 year after the initiation of monotherapy. 1) = 18 years old 2) Best-corrected corrected visual acuity better than 20/40 3) Diagnosed with open-angle glaucoma (high tension glaucoma + normal tension glaucoma) - Open-angle glaucoma was defined as an eye with glaucomatous optic nerve head change and corresponding glaucomatous visual field defects 4) Receive glaucoma monotherapy with bimatoprost 0.01% once daily for more than 1 year
Exclusion criteria
Exclusion criteria: 1) History of intraocular or refractive surgery except simple cataract extraction 2) Moderate to severe dry eye before receiving bimatoprost therapy 3) Exopthalmos or enophthalmos of know etiology before receiving bimatoprost therapy 4) History of orbital and adnexal fractures, traumas, or surgeries 5) Thyroid eye disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean IOP change from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of prostaglandin-associated periorbitopathy (based on the photographic finding);Patients satisfaction, tolerability and adherence based on the questionnaire;Safety evaluation based on the slit-lamp examination (severity of conjunctival hyperemia and punctate keratitis) | — |
Countries
Korea, Republic of
Contacts
Public ContactMi Sun Sung
Chonnam National University Hospital
Outcome results
None listed